Proceedings of the National Academy of Sciences · 1999 · 200 citations · 41 references
MedicineEndocrinologyMolecular BiologyGene ExpressionTranscriptionTranscriptional RegulationCis-regulatory ElementsGene Regulatory ElementsHormonal Gene RegulationNuclear ReceptorsPromoter RegulationTranscription FactorsEstrogen Receptor SignalingEstrogen ReceptorsNuclear Hormone Receptor SignalingNuclear Receptor CoregulatorsTranscriptional RepressionTumor Necrosis Factor Regulation
The tumor necrosis factor-alpha (TNF-alpha) promoter was used to explore the molecular mechanisms of estradiol (E(2))-dependent repression of gene transcription. E(2) inhibited basal activity and abolished TNF-alpha activation of the TNF-alpha promoter. The E(2)-inhibitory element was mapped to the -125 to -82 region of the TNF-alpha promoter, known as the TNF-responsive element (TNF-RE). An AP-1-like site in the TNF-RE is essential for repression activity. Estrogen receptor (ER) beta is more potent than ERalpha at repressing the -1044 TNF-alpha promoter and the TNF-RE upstream of the herpes simplex virus thymidine kinase promoter, but weaker at activating transcription through an estrogen response element. The activation function-2 (AF-2) surface in the ligand-binding domain is required for repression, because anti-estrogens and AF-2 mutations impair repression. The requirement of the AF-2 surface for repression is probably due to its capacity to recruit p160 coactivators or related coregulators, because overexpressing the coactivator glucocorticoid receptor interacting protein-1 enhances repression, whereas a glucocorticoid receptor interacting protein-1 mutant unable to interact with the AF-2 surface is ineffective. Furthermore, receptor interacting protein 140 prevents repression by ERbeta, probably by interacting with the AF-2 surface and blocking the binding of endogenous coactivators. These studies demonstrate that E(2)-mediated repression requires the AF-2 surface and the participation of coactivators or other coregulatory proteins.
41
Molecular basis of agonism and antagonism in the oestrogen receptor
A.M. Brzozowski, A.C.W. Pike, Zbigniew Dauter et al. · Nature · 1997 · 3.3K citations
Yasutomi Kamei, Lan Xu, Thorsten Heinzel et al. · Cell · 1996 · 2.2K citations · Full text
The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women
Steven R. Cummings, Stephen Eckert, D Grady et al. · JAMA · 1999 · 1.9K citations